Teva Pronasal nasal spray

Pronasal is a corticosteroid-based nasal spray used primarily for treating allergic rhinitis and nasal polyps. Its active ingredient, mometasone furoate, helps reduce inflammation in the nasal passages. This specific packaging is printed in Polish and carries the branding of Teva Pharmaceutical Industries, one of the world's leading generic drug manufacturers.

The Teva brand originated in Israel in the early 20th century, emerging from a small wholesale business into a global pharmaceutical powerhouse through strategic acquisitions. Today, Teva operates a vast network of manufacturing facilities across the globe, including significant sites in Europe, North America, and Israel, to supply local and international markets.

Ownership of the brand remains with Teva Pharmaceutical Industries Ltd., headquartered in Tel Aviv, Israel. As a publicly traded company on the New York Stock Exchange and the Tel Aviv Stock Exchange, it functions as its own ultimate parent entity. In Poland, where this specific product is marketed, it is managed through their local subsidiary, Teva Pharmaceuticals Polska.